Skip to content

ADXN

Addex Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.40
+1.19%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 9, 2026
EPS estimate
Revenue estimate

Latest reported

Last report date
Jun 25, 2026
EPS actual
-$1.53
EPS estimate
Revenue actual
$9.9K
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
1
EPS misses (12Q)
8
EPS in line (12Q)
1
Avg surprise (4Q)
-4459.8%
Revenue beats (12Q)
3
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Jun 25, 2026-$1.53$9.9K
Dec 4, 2025-$1.50$37.4K
Jun 20, 2025-$4.26-$1.33Beat 68.77%
Nov 22, 2024-$1.40-$2.77Miss -97.86%$62.7K
Sep 30, 2024-$0.01-$1.77Miss -17600.00%$128.7K
Jun 6, 2024-$0.44-$1.37Miss -210.28%$257.8K
Nov 29, 2023-$4.00-$4.07Miss -1.75%$357.3K
Aug 10, 2023-$0.83-$5.00Miss -506.00%$703.4K
May 11, 2023-$1.03-$5.20Miss -404.19%$546.6K
Mar 9, 2023-$0.31-$0.83Miss -167.74%$640.6K
Nov 11, 2022-$11-$11In line$416.1K
Aug 18, 2022-$11-$24Miss -110.71%$191.4K

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026